Effects of Chemotherapy on Fatigue levels and Quality of life in Cancer patients
Vol. 2 No. 01 (2024), Articles
Vol. 2 No. 01 (2024)

Effects of Chemotherapy on Fatigue levels and Quality of life in Cancer patients

Articles
Published 2024-03-30
Maria Naeem
Riphah International University, Islamabad
Anam Javed
Bashir Institute of Health Sciences, Islamabad
Kanza Sadiq Malik
Bashir Institute of Health Sciences, Islamabad
Syed Isa Shah
Bashir Institute of Health Sciences, Islamabad
Maria Abbas
Bashir Institute of Health Sciences, Islamabad
Haseeb Muhammad Khan
Bashir Institute of Health Sciences, Islamabad

Abstract

Objective:  To determine the effects of chemotherapy treatment on fatigue and quality of life among cancer patients. 

Study design: It was a descriptive cross-sectional survey study.

Place and duration of study: The study participants were the cancer patients enrolled at NORI hospital, Islamabad from July, 2022 to December, 2022.

Material and Methods:  A descriptive cross-sectional survey was performed on the sample size of 50 cancer patients calculated on Rao Software. Tools used were Piper fatigue scale, and Short form health survey instrument (SF-36) to determine the effect of chemotherapy treatment on fatigue and quality of life. The study participants were the cancer patients enrolled at NORI hospital, Islamabad, aged between 30 to 55 years. Data was analyzed through SPSS version 22.

Results: Results showed that 4(8%) participants lie in the mild fatigue category, 22(44%) lie in the moderate, and 24(48%) lie in the severe fatigue category. Based on the scoring of Short form Health Survey (SF-36), 36 participants showed a significant decline in quality of life, while 14 participants had no significant changes in quality of life during chemotherapy treatment.

Conclusion: Chemotherapy has a significant effect on quality of life and fatigue in cancer patients.

Keywords: Chemotherapy, Cancer, Fatigue, Quality of life.  

PDF

References

Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and Cardiovascular Disease Death. Hypertension [Internet]. 2010 Jul 1;56(1):166–71.

Berglund A, Holmberg L, Tishelman C, Wagenius G, Eaker S, Lambe M. Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden. Thorax [Internet]. 2010;65(4):327–33.

Fromer M. New SEER Report Documents High Risk of Second Cancers in Cancer Survivors. Oncol Times [Internet]. 2007;29(5).

Amjad MT, Chidharla A, Kasi A. Cancer Chemotherapy [Internet]. StatPearls Publishing, Treasure Island (FL); 2022.

Pearce A, Haas M, Viney R, Pearson S-A, Haywood P, Brown C, et al. Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study. PLoS One [Internet]. 2017 Oct 10;12(10):e0184360.

Altun İ, Sonkaya A. The most common side effects experienced by patients were receiving first cycle of chemotherapy. Iran J Public Health. 2018;47(8):1218–9.

Harrington ME. Neurobiological studies of fatigue. Prog Neurobiol [Internet]. 2012;99(2):93–105.

Parse RR. The Lived Experience of Feeling Very Tired: A Study Using the Parse Research Method. Nurs Sci Q [Internet]. 2003 Oct 1;16(4):319–25.

Groopman JE, Itri LM. Chemotherapy-Induced Anemia in Adults: Incidence and Treatment. JNCI J Natl Cancer Inst [Internet]. 1999 Oct 6;91(19):1616–34.

Cannavale K, Xu H, Xu L, Sattayapiwat O, Rodriguez R, Bohac C, et al. Epidemiology of Chemotherapy-Induced Anemia in Patients with Non-Hodgkin Lymphoma. Perm J. 2019;23.

Karthikeyan G, Jumnani D, Prabhu R, Manoor UK, Supe SS. Prevalence of fatigue among cancer patients receiving various anticancer therapies and its impact on quality of life: a cross-sectional study. Indian J Palliat Care. 2012 Sep;18(3):165–75.

Gielissen MFM, Verhagen CAHHVM, Bleijenberg G. Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer [Internet]. 2007;97(5):612–8.

Lange M, Joly F. How to Identify and Manage Cognitive Dysfunction After Breast Cancer Treatment. J Oncol Pract [Internet]. 2017 Dec 1;13(12):784–90.

Gledhill JA, Rodary C, Mahé C, Laizet C. [French validation of the revised Piper Fatigue Scale]. Rech Soins Infirm [Internet]. 2002;(68):50–65.

Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum [Internet]. 1998;25(4):677–84.

Pinar R. Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res [Internet]. 2005;14(1):259–64.

Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Br Med J [Internet]. 1992 Jul 18;305(6846):160 LP – 164.

Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, et al. Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy. Cancer [Internet]. 2008 Apr 15;112(8):1845–53.

Polanski J, Jankowska-Polanska B, Rosinczuk J, Chabowski M, Szymanska-Chabowska A. Quality of life of patients with lung cancer. Onco Targets Ther [Internet]. 2016 Dec 31;9:1023–8.

Chan HK, Ismail S. Side effects of chemotherapy among cancer patients in a Malaysian general hospital: Experiences, perceptions and informational needs from clinical pharmacists. Asian Pacific J Cancer Prev. 2014;15(13):5305–9.

Okuyama T, Tanaka K, Akechi T, Kugaya A, Okamura H, Nishiwaki Y, et al. Fatigue in Ambulatory Patients with Advanced Lung Cancer: Prevalence, Correlated Factors, and Screening. J Pain Symptom Manage [Internet]. 2001;22(1):554–64.

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyright (c) 2024 Journal of Nursing and Allied Health